Abingworth as of March 31, 2021
Portfolio Holdings for Abingworth
Abingworth holds 17 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vaxcyte Common (PCVX) | 28.4 | $82M | 4.2M | 19.70 | |
| Phathom Common (PHAT) | 15.6 | $45M | 1.2M | 37.45 | |
| Spruce Bio Common | 10.3 | $30M | 1.8M | 16.59 | |
| Adicet Common (ACET) | 7.2 | $21M | 1.6M | 12.98 | |
| Verona Sponds Adr (VRNA) | 7.0 | $20M | 2.5M | 8.25 | |
| Sientra Common | 6.0 | $17M | 2.4M | 7.26 | |
| Nucana Ads | 5.7 | $17M | 3.3M | 4.97 | |
| Exicure Common | 5.2 | $15M | 7.0M | 2.17 | |
| Sierra Oncology Common | 5.1 | $15M | 871k | 16.90 | |
| Soleno Common | 4.5 | $13M | 10M | 1.26 | |
| Paratek Common | 2.5 | $7.3M | 1.0M | 7.04 | |
| Molecular Templates Common | 0.9 | $2.5M | 200k | 12.56 | |
| X4 Pharma Common (XFOR) | 0.7 | $2.0M | 230k | 8.51 | |
| Aeglea Common | 0.7 | $1.9M | 241k | 7.88 | |
| Cymabay Common | 0.2 | $595k | 131k | 4.54 | |
| Obseva Common | 0.1 | $286k | 88k | 3.25 | |
| Ocugen Common | 0.0 | $48k | 7.1k | 6.75 |
